"Servicios de cardiología para pacientes adultos y pediátricos"

During the past decade, Instituto del Corazon conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto del Corazon" #1 sponsor was "Amaranth Medical Inc." with 3 trials, followed by "Bayer" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Newron Pharmaceuticals SPA" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Instituto del Corazon" are "Coronary Artery Disease" (3 trials), "Myocardial Ischemia" (3 trials), "Cardiovascular Disease" (2 trials), "Atrial Fibrillation" (1 trials) and "Disorder; Heart, Functional, Postoperative, Cardiac Surgery" (1 trials). Many other conditions were trialed in "Instituto del Corazon" in a lesser frequency.

Most popular intervention types in "Instituto del Corazon" are "Drug" (5 trials), "Device" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials), "AmM APTITUDE Bioresorbable Drug-Eluting Coronary Scaffold" (1 trials), "AmM FORTITUDE Bioresorbable Drug-Eluting Coronary Scaffold" (1 trials) and "AmM MAGNITUDE Bioresorbable Drug-Eluting Coronary Scaffold" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto del Corazon" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Instituto del Corazon". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Instituto del Corazon, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto del Corazon, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".